Certania completed the acquisition of Groupe Icare.

Certania, a company that offers a wide range of testing, inspection, certification, and research services in the fields of health, sustainability, materials, and structures, completed the acquisition of Groupe Icare, a provider of laboratory services intended for microbiological analysis of medical devices and pharmaceuticals. Financial terms were not disclosed. “Groupe Icare’s scientific depth and the trust it has built with its clients make it an ideal addition to CERTANIA. Together, we are building a strong and effective platform in the life sciences sector – empowering our clients to navigate an increasingly complex regulatory environment,” Karsten Xander, Certania Founder and CEO.